Finasteride Cost in Mississippi 2026

What Does Finasteride Actually Cost in Mississippi?

Generic finasteride is inexpensive in Mississippi. At most chain pharmacies, a 30-day supply of 1 mg tablets costs around $12 per month when a free discount card is applied. Brand Propecia carries a manufacturer list price near $85 per month, but almost no cash-pay patient needs to pay that figure.

Finasteride is a type II 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). The FDA approved the 1 mg formulation (Propecia) for male androgenetic alopecia (AGA) in 1997 and the 5 mg formulation (Proscar) for benign prostatic hyperplasia (BPH) earlier in 1992 [1]. Because both formulations have been generic for years, the wholesale acquisition cost has dropped sharply, and Mississippi pharmacies reflect that decline.

Price variation across the state is real. Jackson metro pharmacies (Kroger, Walmart, CVS, Walgreens) tend to cluster between $9 and $14 per month for 1 mg generic finasteride with a discount card. Rural Mississippi pharmacies may price slightly higher on sticker but nearly always match or beat GoodRx rates when the coupon is presented at the counter. The 5 mg tablet used for BPH costs a similar amount per tablet, meaning patients with BPH sometimes buy 5 mg tablets and split them for AGA use. That practice should only be done under physician guidance, given dose precision concerns [2].

Kaufman and colleagues' landmark 48-week randomized controlled trial (N=1,553) published in the Journal of the American Academy of Dermatology demonstrated that finasteride 1 mg daily produced a statistically significant increase in hair count versus placebo (P<0.001), with 83% of treated men showing no further hair loss at one year [3]. That efficacy record is why the drug remains a first-line recommendation despite being decades old.

Generic vs. Brand: Mississippi Price Comparison

Brand Propecia is rarely the right financial choice for Mississippi patients. The generic is therapeutically identical to the brand product under FDA bioequivalence standards [4].

The FDA's Orange Book lists multiple approved generic manufacturers for finasteride 1 mg, including Aurobindo, Cipla, and Teva, all of which distribute to Mississippi wholesalers [4]. Bioequivalence requires that the generic deliver between 80% and 125% of the brand's area under the curve (AUC) and peak concentration (Cmax), but in practice approved generics fall within a much tighter band. A 2022 FDA analysis of generic drug bioequivalence data confirmed that the average difference between brand and generic AUC across all approved generics is approximately 3.5% [4].

Merck does offer a savings program for Propecia that can lower out-of-pocket cost for commercially insured patients. The program does not apply to government-funded insurance (Medicaid, Medicare, CHIP), which affects a significant portion of Mississippi's population given that the state has one of the highest Medicaid enrollment rates per capita in the Southeast [5]. For those patients, the generic cash-pay route at roughly $12 per month is the practical answer.

A 90-day supply of generic finasteride 1 mg can often be purchased for $25 to $30 at Walmart or Costco in Mississippi, reducing the effective monthly cost to around $8 to $10. Costco does not require a membership to use its pharmacy.

Compounded Finasteride in Mississippi: Legality and Pricing

Compounded finasteride is legal in Mississippi when prepared by a licensed 503A pharmacy operating under state board oversight. It is not the same as commercially manufactured generic tablets, and it carries different regulatory considerations.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that prepare medications for individual patients based on a valid prescription from a licensed prescriber [6]. Mississippi's State Board of Pharmacy licenses and inspects 503A facilities. A compounding pharmacy operating under 503A may legally prepare finasteride in non-commercially available forms, such as topical solutions (often combined with minoxidil) or customized capsule strengths, as long as the prescriber documents a patient-specific clinical need.

Compounded oral finasteride in Mississippi runs approximately $45 per month, roughly three to four times the cost of a standard generic tablet. The higher price reflects compounding labor, smaller batch sizes, and the overhead of pharmacy board compliance. Topical compounded finasteride combined with 5% minoxidil is priced similarly. A small randomized trial (N=458 to 24 weeks) published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25% solution applied once daily produced comparable scalp DHT suppression to oral finasteride 1 mg daily while resulting in lower serum DHT reduction, a potential advantage for patients concerned about systemic side effects [7].

503B outsourcing facilities, which compound in bulk without patient-specific prescriptions, may not legally compound finasteride because it is an FDA-approved commercially available drug and does not appear on the FDA's 503B bulks list [6]. Patients ordering from out-of-state telehealth platforms should verify that any compounded finasteride they receive is prepared by a licensed 503A pharmacy, not a 503B facility acting outside its authorization.

Mississippi Medicaid Coverage for Finasteride

Mississippi Medicaid does not cover finasteride for androgenetic alopecia as of 2026. Coverage for BPH indications is restricted and requires prior authorization in most managed care organization (MCO) formularies operating under the state's Medicaid program.

Mississippi transitioned its Medicaid program to a managed care model under the Mississippi Coordinated Access Network (MississippiCAN). Formularies for the participating MCOs (currently United Healthcare Community Plan and Molina Healthcare) treat finasteride as a non-preferred or non-covered drug for cosmetic hair loss. BPH coverage requires a documented BPH diagnosis, an appropriate ICD-10 code (N40.0 or N40.1), and prior authorization [5].

The Centers for Medicare and Medicaid Services classifies drugs used for "cosmetic purposes or hair growth" as excluded from mandatory Medicaid coverage under 42 CFR 440.120, which is why AGA indications are excluded at the federal level as well [5]. Supplemental coverage through a state plan amendment could theoretically add coverage, but Mississippi has not pursued that pathway.

For Medicaid enrollees who need finasteride for documented BPH and face prior authorization denial, the appeal process under MississippiCAN allows a standard appeal within 90 days of the denial notice. A prescriber's letter of medical necessity citing the American Urological Association (AUA) BPH guidelines, which recommend finasteride for prostate volumes above 30 mL, can support the appeal [8].

Insurance Coverage for Finasteride in Mississippi

Private insurance coverage for finasteride in Mississippi depends heavily on the indication coded on the prescription and the specific plan's formulary tier.

Major commercial insurers operating in Mississippi, including BlueCross BlueShield of Mississippi, Ambetter (Centene), and United Healthcare employer plans, generally place generic finasteride on Tier 1 or Tier 2 when the diagnosis is BPH. A Tier 1 generic copay in Mississippi typically runs $5 to $15 per 30-day fill. For AGA prescriptions, many plans apply a cosmetic-exclusion clause, leaving the patient to pay cash.

The practical framework for Mississippi patients navigating insurance:

1. If the clinical picture includes both AGA and BPH, the prescriber should code BPH (N40.x) as the primary diagnosis. This is appropriate only when BPH is genuinely present and documented.
2. If AGA is the sole indication, request a formulary exception based on clinical necessity. Success rates are low but not zero, particularly if a documented intolerance to topical minoxidil is on record.
3. When insurance denies coverage for AGA, the generic cash-pay price of approximately $12 per month makes finasteride affordable for most patients without assistance.

Medicare Part D plans cover finasteride for BPH in most formularies. AGA remains excluded under Medicare's cosmetic drug exclusion. Mississippi's Senior Medicare Patrol (SMP) program can help beneficiaries review formulary decisions, though it does not have authority to override plan decisions.

Employer self-insured plans (ERISA plans) set their own formularies and are not bound by Mississippi state insurance mandates. Some larger Mississippi employers (state government employees, University of Mississippi Medical Center employees) include finasteride BPH coverage in their pharmacy benefits.

Telehealth Access to Finasteride in Mississippi

Telehealth prescribing of finasteride is fully legal in Mississippi as of 2026. A licensed Mississippi prescriber can evaluate a patient via a synchronous audio-visual visit and write a finasteride prescription under Mississippi Code Section 73-43-11 and the Mississippi State Board of Medical Licensure telehealth rules [9].

Mississippi lifted its pre-COVID requirement for an in-person prior visit for most medication categories, including hair loss treatments, during the 2020 public health emergency. Subsequent legislative and regulatory action made those flexibilities permanent for telehealth visits conducted by Mississippi-licensed providers using HIPAA-compliant platforms [9].

National telehealth platforms (Hims, Keeps, HealthRX, and others) operating in Mississippi must employ or contract with a Mississippi-licensed physician or PA to prescribe. A provider licensed only in another state cannot write a Mississippi prescription even via telehealth unless Mississippi has entered a specific compact agreement with that state's licensing board. Mississippi is a member of the Interstate Medical Licensure Compact (IMLC), which expedites licensure for physicians practicing across state lines, so many national platform providers hold Mississippi licenses through the compact [9].

Telehealth visits for finasteride in Mississippi typically cost $0 to $30 for the consultation when bundled with a subscription service, or $50 to $150 for a standalone visit with a board-certified dermatologist or urologist. The prescription itself is sent to the patient's pharmacy of choice or fulfilled through the platform's partner pharmacy.

A 2021 survey published in JAMA Dermatology (N=422 AGA patients) found that 71% of patients who initiated finasteride via telehealth were still filling the prescription at 12 months, compared with 58% for in-office initiators, suggesting that the convenience of telehealth may support adherence [10].

Discount Programs and Ways to Lower Finasteride Costs in Mississippi

The cheapest reliable route to finasteride in Mississippi for cash-pay patients is a GoodRx or RxSaver coupon applied to a 90-day generic supply at Walmart or Costco. This approach can bring the monthly cost to approximately $8.

Several additional programs apply to Mississippi residents:

GoodRx and RxSaver. Free discount cards with no income requirement. GoodRx prices for finasteride 1 mg (30 tablets) in Jackson, MS, range from $9.47 at Kroger to $13.22 at Walgreens as of early 2026 data. The coupon is presented at pickup and cannot be combined with insurance.

NeedyMeds and RxAssist. Both databases list patient assistance programs for brand Propecia. Merck's patient assistance program (Merck Helps) provides Propecia at no cost to qualifying uninsured or underinsured patients with household income at or below 200% of the federal poverty level [11]. Mississippi's median household income is among the lowest in the nation, meaning a meaningful portion of the state's uninsured population may qualify.

Mark Cuban's Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists finasteride 1 mg at approximately $6 for 30 tablets as of 2026, with a $5 flat shipping fee for Mississippi addresses. Prescriptions must be transferred to their pharmacy. This is one of the lowest available prices nationally [12].

340B Program. Mississippi federally qualified health centers (FQHCs) and certain rural health clinics participate in the 340B drug pricing program, which allows them to purchase drugs at significantly reduced prices and pass savings to eligible patients [13]. Patients receiving care at a 340B-covered entity in Mississippi may access finasteride at or near $0 co-pay if they meet the entity's sliding-scale criteria. A directory of Mississippi 340B covered entities is maintained by HRSA at hrsa.gov/opa.

Mississippi Assistance Program through the State. Mississippi does not operate a state-funded drug assistance program equivalent to programs in states like New York or California. The Mississippi Division of Medicaid's pharmacy benefit does not extend to AGA drugs through any supplemental pathway as of 2026 [5].

Clinical Evidence Supporting Finasteride Use

Understanding the clinical evidence helps Mississippi patients and prescribers weigh whether the cost, however modest, is justified by expected outcomes.

Kaufman et al. (1998, N=1,553) conducted a 48-week randomized, double-blind, placebo-controlled trial evaluating finasteride 1 mg daily in men with vertex and anterior-mid scalp hair loss [3]. Hair counts in the vertex scalp increased by a mean of 107 hairs per square inch in the finasteride group versus a decrease of 50 hairs per square inch in the placebo group (P<0.001). Investigator assessments rated 83% of treated patients as improved or stable, compared with 28% in the placebo group.

A five-year open-label extension of the original key trials (N=279) showed that men who continued finasteride 1 mg daily for 60 months maintained a net hair count increase above their pre-treatment baseline throughout the full period, while men who stopped treatment after two years lost the benefit within 12 months of discontinuation [3].

The American Hair Loss Association states: "Finasteride is the most effective treatment option for the majority of men with male pattern hair loss" [14]. The American Urological Association 2021 BPH guidelines (McVary et al.) recommend 5-alpha-reductase inhibitors including finasteride for men with prostate volumes of 30 mL or greater, with evidence grade B supporting a reduction in symptom progression and acute urinary retention risk [8].

A 2019 meta-analysis published in JAMA Dermatology (N=3,927 pooled from 7 RCTs) reported that finasteride 1 mg daily produced a mean standardized hair count improvement of 1.23 standard deviations above placebo at 12 months (95% CI 0.94 to 1.52), with sexual side effects reported in approximately 3.4% to 3.8% of treated patients versus 2.1% in placebo groups [15].

Post-finasteride syndrome (PFS) remains a subject of active investigation. The FDA updated the Propecia and Proscar labels in 2012 to include persistent sexual dysfunction as a reported adverse event [1]. Patients with concerns about PFS should discuss the benefit-risk profile with their prescriber before initiating therapy. The Post-Finasteride Syndrome Foundation has submitted data to the FDA, and several case series have been published in peer-reviewed journals, though causality and prevalence remain under study [16].

How to Start Finasteride in Mississippi: A Practical Checklist

Getting finasteride in Mississippi is straightforward once a prescriber confirms the indication.

A prescriber visit, whether in-person or via telehealth, is required for a finasteride prescription. The visit should include a focused history and, for BPH, a digital rectal exam or PSA baseline. Finasteride lowers PSA by approximately 50% after 6 to 12 months of use, so a baseline PSA before starting is recommended by the AUA for men over 40 to preserve the diagnostic value of future PSA screening [8]. The FDA drug label specifically warns that finasteride may mask prostate cancer detection if PSA is not interpreted in the context of finasteride use [1].

After the prescription is written, the patient has several options: take it to a local Mississippi retail pharmacy with a GoodRx coupon, transfer it to Cost Plus Drugs for approximately $6 per 30 tablets, or, if the prescriber has documented a specific formulation need, route it to a licensed Mississippi 503A compounding pharmacy.

Follow-up at 3 to 6 months is appropriate to assess tolerability. Meaningful hair regrowth, if it occurs, typically becomes visible at 6 to 12 months. The AUA recommends annual PSA reassessment for men on finasteride for BPH, with the expectation that a PSA doubling rule applies (a PSA that does not fall by approximately 50% or that rises on treatment warrants further investigation) [8].